Information Journal Paper
APA:
Copy. (2017). 5 years safety of fingolimod in real world: First results from PANGAEA, a noninterventional study of RRMS patients treated with fingolimod, on safety and adherence after 5 years of fingolimod in daily clinical practice. NEUROLOGY, 88(SUPPLEMENT 16), 0-0. SID. https://sid.ir/paper/732589/en
Vancouver:
Copy. 5 years safety of fingolimod in real world: First results from PANGAEA, a noninterventional study of RRMS patients treated with fingolimod, on safety and adherence after 5 years of fingolimod in daily clinical practice. NEUROLOGY[Internet]. 2017;88(SUPPLEMENT 16):0-0. Available from: https://sid.ir/paper/732589/en
IEEE:
Copy, “5 years safety of fingolimod in real world: First results from PANGAEA, a noninterventional study of RRMS patients treated with fingolimod, on safety and adherence after 5 years of fingolimod in daily clinical practice,” NEUROLOGY, vol. 88, no. SUPPLEMENT 16, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/732589/en